openPR Logo
Press release

Drug Development: Vela Laboratories and Anagnostics enter strategic partnershipto offer hybcell technology to biotech and pharma customers under GMP conditions

02-10-2012 06:54 AM CET | Health & Medicine

Press release from: Anagnostics Bioanalysis GmbH

/ PR Agency: Impuls Public Relations OG
hybcell: cylindrical microarray for DNA and protein analytics, Image copyright:Anagnostics (imprint free of charge)

hybcell: cylindrical microarray for DNA and protein analytics, Image copyright:Anagnostics (imprint free of charge)

Companionship in clinical studies: patient stratification by cost-effective compact sequencing is a first step.
Affinity and Immunogenicity: hybcell as an alternative to SPR (surface plasmon resonance) technology for larger sample collectives will be tested and positioned.

Viennese Vela Laboratories are among the leading companies offering efficacy and release testing for biopharmaceuticals under GMP conditions (Good Manufacturing Practice). Vela Laboratories and Anagnostics have agreed upon a strategic partnership in the fields of analytical services and marketing and sales in the area of services for drug discovery units.
‘The fast growing demand in the field of Biosimilars - Comparability Testing results in a need for creative business models. Vela obtained international reputation within the market for complete characterisation of Biopharmaceuticals, Biologics and Biosimilars and is among the top tier suppliers of ICH Q6B conform protein analytics. Anagnostics hybcell technology offers totally new analytical solutions, which we want to offer our customers. Together we can serve our customers more efficiently and comprehensively’ comments Dr. Markus Fido, CEO of Vela Laboratories, the decision of his company.
‘Synergies stemming from Anagnostics’ innovative analytical approaches and the outstanding expertise of Vela Laboratories enable Anagnostics to speed up the market penetration in the field of drug discovery’, is highlighted by Christoph Reschreiter, CEO of Anagnostics Bioanalysis GmbH.

Patient stratification / Affinity Measurement
In a first step Anagnostics’ compact sequencing should be applied for patient stratification during clinical studies – for example a test for mutations in the KRAS and BRAF gene.
In a second step Anagnostics’ affinity and immunogenicity measurement will be applied for the characterisation of drug candidates. In comparison to state of the art methods like SPR (surface plasmon resonance) hybcell offers far more capacity for simultaneous examinations of samples and is less vulnerable to interferences (higher selectivity). Another aspect is the ability of hybcell tests to be stored over long periods of time. Especially for long-term projects this aspect could be an advantage for researchers, as they can compare new drug candidates under the same conditions that were applied for examinations earlier in the project.

Leading services for efficacy and release testing of biopharmaceuticals
Vela Laboratories is an internationally active GMP certified contract research/analytics laboratory. Vela offers a broad portfolio of analytical methods, especially for characterisation of proteins. Vela Laboratories offer customer specific analytical services. The highly motivated team of experts focuses on assay development and quality control to serve customers in pre-clinical and clinical developments (market approvals).

Multiplex diagnostics focusing on routine test in drug discovery and clinical diagnostics.
Austrian Anagnostics Bioanalysis focuses on development and production of systems and tests for analytics in drug development (affinity, immunogenicity…) and clinical diagnostics (drugs of abuse, oncology and severe infections…). The combination of DNA- and protein tests on the same device (hyborg) enables innovative and efficient diagnostic solutions for the rapidly growing demand driven by personalized medicine.
Since 2005 a young team around molecular geneticist and biochemist Dr. Bernhard Ronacher develops multiplexed analytical systems (hyborg) and tests (hybcells). The patented hybcell is the world’s first cylindrical microarray and core of Anagnostics’ technology. Based on this hybcell, complete test kits are assembled and fully automated processed by hyborg.

Press contact:
Impuls Public Relations OG | Mag. Anita Reschreiter
A-4020 Linz | Bürgerstraße 26 | Tel. +43 (0)664/1604209

Anagnostics Bioanalysis GmbH | Mag. Christoph Reschreiter
A-4300 St. Valentin | Westbahnstraße 55 | Tel. +43 (0)7435 58193-0

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Development: Vela Laboratories and Anagnostics enter strategic partnershipto offer hybcell technology to biotech and pharma customers under GMP conditions here

News-ID: 210348 • Views: 1305

More Releases from Anagnostics Bioanalysis GmbH

Anagnostics and Sony DADC announce European collaboration
Sony DADC is taking charge of production of the smart consumables components of Anagnostics’ hybcell-tests. This joint development of the hybcell tests will enhance the effectiveness of the laboratory tests and advance the integration and automation of their production. Sony DADC BioSciences is a worldwide leader in the development and production of plastic consumables and technical coatings used in medical technology. The company, based in Anif near Salzburg, is particularly successful
Smart cancer diagnostics from Austria impresses in Italy: tecnet supports succes …
St. Pölten / St. Valentin, October 28, 2011 – A globally unique diagnostics tool for routine medical operations is now available in Italy for the first time. To this end, the Austrian company Anagnostics Bioanalysis GmbH has agreed to enter into a sales partnership with Italian Cell.ENG s.r.l. with immediate effect. The Italian company is thus being granted the rights of sale of an innovative tool for the identification of

More Releases for Vela

Algorithm Trading Market Is Booming Worldwide | Thomson Reuters, Tata Consulting …
The latest independent research document on Global Algorithm Trading examine investment in Market. It describes how companies deploying these technologies across various industry verticals aim to explore its potential to become a major business disrupter. The Algorithm Trading study eludes very useful reviews & strategic assessment including the generic market trends, emerging technologies, industry drivers, challenges, regulatory policies that propel the market growth, along with major players profile and strategies.
Multiviewer Monitoring System Market 2022 | COVID-19 Impact Analysis Report and …
The Global Multiviewer Monitoring System Market Research Report 2022-2030 is a valuable source of insightful data for business strategists. It provides the Market overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report. Click
Profitable Strategic Report on Automated Algo Trading Market With Included Anal …
The latest release from WMR titled Automated Algo Trading Market Research Report 2022-2028 (by Product Type, End-User / Application, and Regions / Countries) provides an in-depth assessment of the Automated Algo Trading including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles, and strategies. Global Automated Algo Trading Market study with 100+ market data Tables, Pie Chat, Graphs & Figures is now released BY WMR.
Next Generation PCR Equipment Market to Witness Huge Growth by Key Players: Gene …
Global Next Generation PCR Equipment Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables
Multiviewer Monitoring System Market Analysis, Promising Growth Opportunities an …
QY Research has Published Latest Trending Report on Global Multiviewer Monitoring System Market  Los Angeles, United State, – The report titled Multiviewer Monitoring System Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Multiviewer Monitoring System market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges,
Zika Virus Testing Market Comprehensive Insights and Growth Potential In The Fut …
Zika Virus Testing Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Zika Virus Testing industry with a focus on the Chinese market. The report provides key statistics on the market status of the Zika Virus Testing manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an